These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11650658)

  • 1. Perspectives on the FDA status of drug products manufactured by the recombinant DNA technique.
    Korwek EL; Trinker DS
    Food Drug Cosmet Law J; 1981 Oct; 36(10):517-35. PubMed ID: 11650658
    [No Abstract]   [Full Text] [Related]  

  • 2. Private rights to adulterated/misbranded articles.
    McMonagle L
    AIDS Public Policy J; 1987; 2(2):33-49. PubMed ID: 11650029
    [No Abstract]   [Full Text] [Related]  

  • 3. The NIH Guidelines for recombinant DNA research and the authority of FDA to require compliance with the Guidelines.
    Korwek EL
    Food Drug Cosmet Law J; 1980 Nov; 35(11):633-50. PubMed ID: 11661977
    [No Abstract]   [Full Text] [Related]  

  • 4. Rules to protect drug-test participants via follow-up exams are slated by FDA.
    Spivak J
    Wall St J (East Ed); 1976 Mar; ():5. PubMed ID: 11649042
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulating biotechnology.
    McGarity TO
    Issues Sci Technol; 1985; 1(3):40-56. PubMed ID: 11649701
    [No Abstract]   [Full Text] [Related]  

  • 6. The regulation of clinical investigators.
    Endries RN
    Food Drug Cosmet Law J; 1980 Jul; 35(7):415-23. PubMed ID: 11661860
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of the Human Genome Project at the interface between patent and FDA laws.
    Cunningham BC
    Risk; 1996; 7(3):253-66. PubMed ID: 11655078
    [No Abstract]   [Full Text] [Related]  

  • 8. Protecting human research subjects and the public: the role of FDA disqualification of clinical investigators.
    Nightingale SL
    Food Drug Cosmet Law J; 1980 Sep; 35(9):484-92. PubMed ID: 11661914
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of genetic modification of organisms: science or emotion?
    Malinowski MJ
    J Biolaw Bus; 1998; 1(3):3-7. PubMed ID: 11657280
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA treatment use regulations: a compassionate response.
    Weitzman SA; Marcy T
    AIDS Public Policy J; 1987; 2(2):22-32. PubMed ID: 11650028
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulating genetic engineering in an era of increased judicial deference: a proper balance of the federal powers.
    Von Oehsen WH
    Adm Law Rev; 1988; 40(3):303-44. PubMed ID: 11650827
    [No Abstract]   [Full Text] [Related]  

  • 12. Resolution: RU 486.
    American Association for the Advancement of Science
    Science; 1991 Apr; 252(5005):587. PubMed ID: 11642875
    [No Abstract]   [Full Text] [Related]  

  • 13. RU 486 and the politics of drug regulation in the United States and France.
    Kramnick RK
    Cornell Int Law J; 1992; 25():667-718. PubMed ID: 11656340
    [No Abstract]   [Full Text] [Related]  

  • 14. AIDS treatment drugs: clinical trials and compassionate use.
    Levine RJ
    AIDS Public Policy J; 1987; 2(2):6-8. PubMed ID: 11650031
    [No Abstract]   [Full Text] [Related]  

  • 15. Implications of the federal drug investigation and approval processes for the development and availability of AIDS treatments and vaccines.
    Mathers PR
    AIDS Public Policy J; 1987; 2(2):50-3. PubMed ID: 11650030
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental drugs: more of them, but they're no longer free.
    Caplan J
    Hastings Cent Rep; 1987 Jun; 17(3):3. PubMed ID: 11644019
    [No Abstract]   [Full Text] [Related]  

  • 17. Anatomy of a regulation: the continuing case of research on prisoners.
    Hastings Cent Rep; 1981 Oct; 11(5):2-3. PubMed ID: 11643672
    [No Abstract]   [Full Text] [Related]  

  • 18. Corporate responsibility for recombinant DNA activities.
    Berger BA
    Univ Toledo Law Rev; 1981; 12(4):913-24. PubMed ID: 11649592
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of genetic engineering: less concern about Frankensteins but time for action on commercial production.
    Karny GM
    Univ Toledo Law Rev; 1981; 12(4):815-68. PubMed ID: 11649588
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical and psychological experimentation on California prisoners.
    Herch F; Flower R
    Univ Calif Davis Law Rev; 1974; 7():351-84. PubMed ID: 11661107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.